Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 1, 2002, Pages 57-59

  Rosenthal, Eric ^a   Poizot Martin, Isabelle ^a   Saint Marc, Thierry ^a   Spano, Jean Philippe ^a   Cacoub, Patrice ^a   Carbon, ^a   Benselama, ^a   Cassuto, ^a   Coulaud, ^a   Bouchaud, ^a   Dupont, ^a   Frottier, ^a   Meynard, ^a   Gastaut, ^a   Imbert, ^a   Picard, ^a   Kazatchkine, ^a   Piketty, ^a   Gilquin, ^a   Massip, ^a   Obadia, ^a   Peyramond, ^a   Blay, ^a   Raffi, ^a   Milpied, ^a   Tourraine, ^a   Vittecocq, ^a   Escaut, ^a   more..

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

AIDS; Kaposi sarcoma; Liposomal daunorubicin

Indexed keywords

ANTIRETROVIRUS AGENT; DAUNORUBICIN; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHASE 4 CLINICAL TRIAL; TREATMENT OUTCOME; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DAUNORUBICIN; FEMALE; HUMANS; LIPOSOMES; MALE; MIDDLE AGED; SARCOMA, KAPOSI;

EID: 0036161926     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200202000-00012     Document Type: Article

References (9)

1. Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection
2. Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma
3. Polychemotherapies in AIDS-related Kaposi's sarcoma
4. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin
5. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma
6. Kaposi's sarcoma in the acquired immune deficiency syndrome: A proposal for uniform evaluation, response, and staging criteria
7. Complete regression of AIDS-related Kaposi's sarcoma in a child treated with highly active antiretroviral therapy
8. Ergotism related to concurrent administration of ergotamine tartrate and indinavir
9. The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma